FDA approves controversial Biogen Alzheimer’s drug | DW News

Subscribe to The Global Herald in Google News

DW News published this video item, entitled “FDA approves controversial Biogen Alzheimer’s drug | DW News” – below is their description.

US government health officials have approved the first new drug for Alzheimer’s disease in nearly twenty years. Regulators say the drug, which will be known as Aduhelm, is the first treatment that targets the causes of the disease, rather than its symptoms. But the approval is controversial – with some experts saying there’s not enough firm evidence of real benefits.

DW News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

Subscribe to The Global Herald in Google News

About This Source - DW News

DW News is a global English-language news and information channel from German public international broadcaster Deutsche Welle, established in summer 2015.

Recent from DW News:

  • How Spain got to the top of the vaccination ladder | DW News
  • Merkel meets with Erdogan on final visit to Turkey: What now? | DW News
  • NASA launches ‘Lucy’ space probe to find origins of solar system | DW News
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.